GGrantIndex
← Leaderboards

Evangelos Kiskinis

Northwestern University

$8,798,472
Attributed
$10,736,475
Total exposure
10
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY201825
$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,736,475 · 10

By mechanism

R01$6,574,156 · 4
U54$1,948,142 · 1
R21$1,727,916 · 4
P50$486,261 · 1

Top collaborators

Most similar at Northwestern University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Neurons

Research focus

NeuronsInduced Pluripotent Stem CellMutationGenesExperimental StudyGeneticCrispr/Cas TechnologyCellsMutantDefectIn VitroFunctional DisorderMotor NeuronsIn VivoLinkMolecularGenetic VariantProteinsLightProteomicsAmyotrophic Lateral SclerosisInduced Pluripotent Stem Cell Derived NeuronsCoupledCell Line

Grant awards (24)

Pathophysiology of KCNQ2-related Disorders$874,094
R01 · FY2025 · NS
Investigating the Contribution of ALS/FTD-Associated Mutations in the NEK1 Kinase to Disease Pathophysiology$759,016
R01 · FY2025 · NS · contact PI
Refining iPSC-Based Spinal Cord Model Systems by Fabricating Developmentally Programmed Extracellular Matrix Cues$533,084
R01 · FY2025 · AG · contact PI
Establishing iPSC-based models to investigate the mechanistic interaction between neurotrauma and ALS/FTD$438,606
R21 · FY2025 · NS · contact PI
Neurodevelopmental Stem Cell core$243,131
P50 · FY2025 · MH · contact PI
Investigating the Contribution of ALS/FTD-Associated Mutations in the NEK1 Kinase to Disease Pathophysiology$751,016
R01 · FY2024 · NS · contact PI
Refining iPSC-Based Spinal Cord Model Systems by Fabricating Developmentally Programmed Extracellular Matrix Cues$559,496
R01 · FY2024 · AG · contact PI
Neurodevelopmental Stem Cell core$243,130
P50 · FY2024 · MH · contact PI
Defining the Mechanisms by Which Mutations in DNAJC7 Increase Susceptibility to ALS/FTD$189,915
R21 · FY2024 · NS · contact PI
Investigating the Contribution of ALS/FTD-Associated Mutations in the NEK1 Kinase to Disease Pathophysiology$766,016
R01 · FY2023 · NS · contact PI
Defining the Mechanisms by Which Mutations in DNAJC7 Increase Susceptibility to ALS/FTD$230,395
R21 · FY2023 · NS · contact PI
Determining How Defective Nucleo-Cytoplasmic Trafficking Leads To Neurodegeneration In C9orf72-Related ALS And FTD$369,956
R01 · FY2022 · NS · contact PI
Project 2 - Investigation of human neuron models of channelopathy-associated epilepsy$362,013
U54 · FY2022 · NS · contact PI
Determining How Defective Nucleo-Cytoplasmic Trafficking Leads To Neurodegeneration In C9orf72-Related ALS And FTD$376,893
R01 · FY2021 · NS · contact PI
Project 2 - Investigation of human neuron models of channelopathy-associated epilepsy$368,420
U54 · FY2021 · NS · contact PI
Determining How Defective Nucleo-Cytoplasmic Trafficking Leads To Neurodegeneration In C9orf72-Related ALS And FTD$511,285
R01 · FY2020 · NS · contact PI
Project 2 - Investigation of human neuron models of channelopathy-associated epilepsy$341,745
U54 · FY2020 · NS · contact PI
Determining How Defective Nucleo-Cytoplasmic Trafficking Leads To Neurodegeneration In C9orf72-Related ALS And FTD$522,342
R01 · FY2019 · NS · contact PI
Project 2 - Investigation of human neuron models of channelopathy-associated epilepsy$475,631
U54 · FY2019 · NS · contact PI
Defining The Mechanisms by Which NEK1 Genetic Variants Associated with ALS Patient Motor Neurons Lead to Motor Neuron Degeneration$434,500
R21 · FY2019 · NS · contact PI
Defining The Impaired Proteostasis Network in ALS Patient Motor Neurons$197,500
R21 · FY2019 · NS · contact PI
Determining How Defective Nucleo-Cytoplasmic Trafficking Leads To Neurodegeneration In C9orf72-Related ALS And FTD$550,958
R01 · FY2018 · NS · contact PI
Project 2 - Investigation of human neuron models of channelopathy-associated epilepsy$400,333
U54 · FY2018 · NS · contact PI
Defining The Impaired Proteostasis Network in ALS Patient Motor Neurons$237,000
R21 · FY2018 · NS · contact PI